it is concluded that diagnostic and clinical treatment with hyperosmotic solutions of nonmetabolizable agents can account for disturbed left ventricular compliance and decreased cardiac performance , as it may occur in hyperosmolar diabetic coma .
C0225897
left
C0018787
cardiac